Glutathione depletion sensitizes cisplatin- and temozolomide-resistant glioma cells in vitro and in vivo

Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma

(2012) Shinji Kohsaka et al.   CANCER LETTERS

Molecular mechanisms of temozolomide resistance in glioblastoma multiforme

(2012) Tor-Christian Aase Johannessen et al.   Expert Review of Anticancer Therapy

NovelXPG(ERCC5) Mutations AffectDNARepair and Cell Survival after Ultraviolet but not Oxidative Stress

(2012) Daniela T. Soltys et al.   HUMAN MUTATION

The glutathione transferase inhibitor 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol (NBDHEX) increases temozolomide efficacy against malignant melanoma

(2011) Lucio Tentori et al.   EUROPEAN JOURNAL OF CANCER

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

(2011) Dagmar Beier et al.   Molecular Cancer

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

γH2Ax: Biomarker of Damage or Functional Participant in DNA Repair “All that Glitters Is not Gold!”

(2011) James E. Cleaver   PHOTOCHEMISTRY AND PHOTOBIOLOGY

Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production

(2011) Claudia R. Oliva et al.   PLoS One

Negative Regulation of p53 by the Long Isoform of ErbB3 Binding Protein Ebp1 in Brain Tumors

(2010) C. K. Kim et al.   CANCER RESEARCH

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

(2009) Roger Stupp et al.   LANCET ONCOLOGY

Platinum Resistance: The Role of DNA Repair Pathways

(2008) L. P. Martin et al.   CLINICAL CANCER RESEARCH

Kinetics of H2AX phosphorylation after exposure to cisplatin

(2008) Peggy L. Olive et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Malignant Gliomas in Adults

(2008) Patrick Y. Wen et al.   NEW ENGLAND JOURNAL OF MEDICINE